Author

Elizabeth Wieland

Observed institutions: The University of Texas MD Anderson Cancer Center, Trillium Therapeutics (Canada)

OpenAlex ID: A5066397614

Simulating Time-Dependent Patterns of Nonadherence by Patients With Breast Cancer to Adjuvant Oral Endocrine Therapy

2019 · Eileen H. Shinn, Gordon Broderick, et al. · JCO Clinical Cancer Informatics · 19

A First-in-Human (FIH) Phase 1 Study of the Anti-LILRB4 Antibody IO-202 in Relapsed/Refractory (R/R) Myelomonocytic and Monocytic Acute Myeloid Leukemia (AML) and R/R Chronic Myelomonocytic Leukemia (CMML)

2020 · Courtney D. DiNardo, Daniel A. Pollyea, et al. · Blood · 10

A phase 1 study of TTI-621, a novel immune checkpoint inhibitor targeting CD47, in subjects with relapsed or refractory hematologic malignancies.

2016 · Stephen Maxted Ansell, Robert W. Chen, et al. · Journal of Clinical Oncology · 10

Works count: 3

Citation count: 39

H-index: 3

I10-index: 3